Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Nasopharyngeal Carcinoma 35Esophageal Squamous Cell Carcinoma 19Carcinoma, Non-Small-Cell Lung 19Carcinoma, Hepatocellular 18Squamous Cell Carcinoma of Head and Neck 15Triple Negative Breast Neoplasms 14Breast Neoplasms 12Uterine Cervical Neoplasms 11Colorectal Neoplasms 11Small Cell Lung Carcinoma 10Melanoma 10Carcinoma, Renal Cell 9Stomach Neoplasms 8Recurrence 8Head and Neck Neoplasms 6Rectal Neoplasms 5Neoplasm Metastasis 5Esophageal Neoplasms 5Carcinoma, Transitional Cell 5Advanced Solid Tumor 5Urinary Bladder Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Neoplasms 4Liver Neoplasms 4Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Cholangiocarcinoma 4Solid Tumor 3Lung Neoplasms 3

Interventions

Cisplatin 24Gemcitabine 16Radiotherapy, Intensity-Modulated 14Fluorouracil 7Radiotherapy 5Docetaxel 5pembrolizumab 4Surveys and Questionnaires 4Carboplatin 4Bevacizumab 4spartalizumab 3camrelizumab 3Induction Chemotherapy 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3toripalimab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Psychiatric Rehabilitation 2Paclitaxel 2Nivolumab 2Immunohistochemistry 2Drug Therapy 2Chemoradiotherapy 2Celecoxib 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Neoplasms × toripalimab × Clear all
NCT05628922 2022-11-29

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Fudan University

Phase 2 Recruiting
198 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT04446663 2020-06-25

Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma

First People's Hospital of Foshan

Phase 2 Unknown
50 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡